Parsonex Advisory Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Sell
32,131
-361
-1% -$19.6K 1.19% 25
2026
Q1
$2.04M Buy
32,492
+5,887
+22% +$471K 1.99% 25
2025
Q4
$2.54M Buy
26,605
+349
+1% +$34.2K 1.62% 21
2025
Q3
$2.56M Buy
26,256
+6,012
+30% +$623K 1.74% 21
2025
Q2
$2.17M Buy
+20,244
New +$2.05M 1.81% 20

Other funds holding BSX

Parsonex Advisory Services's BSX Position: Q2 2026 in Review

Parsonex Advisory Services reduced its Boston Scientific (BSX) stake by 1.1% in Q2 2026, selling an estimated $19.6K and leaving 32,131 shares worth $1.37M. The position accounts for 1.19% of the portfolio, ranked #25.

Parsonex Advisory Services first reported a position in BSX in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.56M in Q3 2025. 1,465 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Parsonex Advisory Services held 32,131 shares of Boston Scientific worth $1.37M as of Q2 2026.
  • Parsonex Advisory Services sold 361 Boston Scientific shares in Q2 2026, an estimated $19.6K.
  • Boston Scientific made up 1.19% of Parsonex Advisory Services's portfolio in Q2 2026, its #25 holding.
  • Parsonex Advisory Services first reported a position in Boston Scientific in Q2 2025 and has held it in 5 quarters since.
  • Parsonex Advisory Services's Boston Scientific position peaked at $2.56M in Q3 2025.
  • 1,465 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Parsonex Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.